TY - JOUR
T1 - Arrhythmias in oncological patients
T2 - a compact overview for the clinician
AU - Iliodromitis, Konstantinos
AU - Hoiczyk, Mathias
AU - Bimpong-Buta, Nana Yaw
AU - Seyfarth, Melchior
AU - Bogossian, Harilaos
N1 - Publisher Copyright:
© The Author(s), under exclusive licence to Springer Medizin Verlag GmbH, ein Teil von Springer Nature 2024.
PY - 2024
Y1 - 2024
N2 - Chemotherapy is the cornerstone of antineoplastic treatment in patients with malignancies. The cardiotoxic effect of antineoplastic therapy has been known for many decades. Part of chemotherapy-induced cardiotoxicity is the development of heart rhythm disturbances. This short review aims to provide a compact overview for the clinical cardiologist of the dysrhythmic potential created by antineoplastic agents in cancer survivors.
AB - Chemotherapy is the cornerstone of antineoplastic treatment in patients with malignancies. The cardiotoxic effect of antineoplastic therapy has been known for many decades. Part of chemotherapy-induced cardiotoxicity is the development of heart rhythm disturbances. This short review aims to provide a compact overview for the clinical cardiologist of the dysrhythmic potential created by antineoplastic agents in cancer survivors.
KW - Antineoplastic agents
KW - Cancer survivors
KW - Cardiotoxicity
KW - Chemotherapy
KW - Dysrhythmic potential
UR - http://www.scopus.com/inward/record.url?scp=85201323364&partnerID=8YFLogxK
U2 - 10.1007/s00399-024-01033-x
DO - 10.1007/s00399-024-01033-x
M3 - Article
C2 - 39129002
AN - SCOPUS:85201323364
SN - 0938-7412
JO - Herzschrittmachertherapie und Elektrophysiologie
JF - Herzschrittmachertherapie und Elektrophysiologie
ER -
